Literature DB >> 15019082

Successful in silico predicting of intestinal lymphatic transfer.

René Holm1, Jan Hoest.   

Abstract

The possibility of developing a quantitative relationship between molecular structure and lymphatic transfer of lipophilic compounds co-administered with a long-chain triglyceride vehicle was examined. Molecular descriptors were calculated using the computer program VolSurf, and lymphatic transfer data were derived from the literature. A significant structure-property relationship was established using partial least squares, projection to latent structures statistics (PLS). R(2)X was 0.77, R(2)Y was 0.83 and the prediction power of Q(2) was 0.73 in the two-component PLS model. A number of descriptors contributed to the prediction leading to a complex model, but the prediction power was improved with the PLS model when compared to the frequently used method by relating logP values (LogKow) with lymphatic transfer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15019082     DOI: 10.1016/j.ijpharm.2003.12.017

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  13 in total

Review 1.  Modeling kinetics of subcellular disposition of chemicals.

Authors:  Stefan Balaz
Journal:  Chem Rev       Date:  2009-05       Impact factor: 60.622

2.  The mesenteric lymph duct cannulated rat model: application to the assessment of intestinal lymphatic drug transport.

Authors:  Natalie L Trevaskis; Luojuan Hu; Suzanne M Caliph; Sifei Han; Christopher J H Porter
Journal:  J Vis Exp       Date:  2015-03-06       Impact factor: 1.355

Review 3.  From sewer to saviour - targeting the lymphatic system to promote drug exposure and activity.

Authors:  Natalie L Trevaskis; Lisa M Kaminskas; Christopher J H Porter
Journal:  Nat Rev Drug Discov       Date:  2015-10-16       Impact factor: 84.694

4.  Bioavailability of seocalcitol IV: evaluation of lymphatic transport in conscious rats.

Authors:  Mette Grove; Jeanet L Nielsen; Gitte P Pedersen; Anette Müllertz
Journal:  Pharm Res       Date:  2006-10-18       Impact factor: 4.200

5.  Exploring the impact of drug properties on the extent of intestinal lymphatic transport - in vitro and in vivo studies.

Authors:  Emma Lawless; Brendan T Griffin; Aoife O'Mahony; Caitriona M O'Driscoll
Journal:  Pharm Res       Date:  2014-11-27       Impact factor: 4.200

6.  The role of the intestinal lymphatics in the absorption of two highly lipophilic cholesterol ester transfer protein inhibitors (CP524,515 and CP532,623).

Authors:  Natalie L Trevaskis; Claire L McEvoy; Michelle P McIntosh; Glenn A Edwards; Ravi M Shanker; William N Charman; Christopher J H Porter
Journal:  Pharm Res       Date:  2010-03-11       Impact factor: 4.200

7.  Enhanced solubility and oral bioavailability of γ-tocotrienol using a self-emulsifying drug delivery system (SEDDS).

Authors:  Saeed Alqahtani; Alaadin Alayoubi; Sami Nazzal; Paul W Sylvester; Amal Kaddoumi
Journal:  Lipids       Date:  2014-06-17       Impact factor: 1.880

8.  Nonlinear absorption kinetics of self-emulsifying drug delivery systems (SEDDS) containing tocotrienols as lipophilic molecules: in vivo and in vitro studies.

Authors:  Saeed Alqahtani; Alaadin Alayoubi; Sami Nazzal; Paul W Sylvester; Amal Kaddoumi
Journal:  AAPS J       Date:  2013-04-10       Impact factor: 4.009

9.  Evaluation of Pharmacokinetics, and Bioavailability of Higher Doses of Tocotrienols in Healthy Fed Humans.

Authors:  Asaf A Qureshi; Dilshad A Khan; Neerupma Silswal; Shahid Saleem; Nilofer Qureshi
Journal:  J Clin Exp Cardiolog       Date:  2016-04-28

Review 10.  Advanced drug delivery to the lymphatic system: lipid-based nanoformulations.

Authors:  Arshad Ali Khan; Jahanzeb Mudassir; Noratiqah Mohtar; Yusrida Darwis
Journal:  Int J Nanomedicine       Date:  2013-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.